Skip to main content
. 2019 Aug 24;8(9):1306. doi: 10.3390/jcm8091306

Table 3.

Alleles and genotypes frequencies for ESR1 c.454-351A>G (XbaI) polymorphism.

ESR1 c.454-351A>G (XbaI)
Genotype Frequencies (%) Allele Frequencies (%)
GG GA AA G
* 1000Genomes: 30.8%
A
* 1000Genomes: 69.2%
IBD
(all patients) n = 198
21 (9.6%) 98 (49.0%) 79 (41.4%) 140 (35.4%) 256 (64.6%)
UC patients (n = 98) 11 (11.2%) 47 (48.0%) 40 (40.8%) 69 (35.2%) 127 (64.8%)
CD patients (n = 100) 10 (10.0%) 51 (51.0%) 39 (39.0%) 71 (35.5%) 129 (64.5%)
CG (n = 41) 2 (4.9%) 19 (46.3%) 20 (48.8%) 23 (28.0%) 59 (72.0%)
Comparisons of allelic and genotypic frequencies between groups under study
[GG + GA] vs. [AA] [GG] vs. [GA + AA] [GG] vs. [AA] [G] vs. [A] [A] vs. [G]
CG vs. IBD
OR, 95% CI
P-value
OR = 0.70 CI = [0.36–1.37] P = 0.293 OR = 2.31 CI = [0.52–10.28] P = 0.258 OR = 2.66 CI = [0.58–12.29] P = 0.196 OR = 1.40 CI = [0.83–2.37] OR 0.71 CI = [0.42–1.20]
P = 0.204
CG vs. UC
OR, 95% CI
P-value
OR = 0.72 CI = [0.35–1.51] P = 0.387 OR = 2.47 CI = [0.52–11.65] P = 0.241 OR = 2.75 CI = [0.56–13.61] p = 0.201 OR = 1.39 CI = [0.79–2.45] OR = 0.71 CI = [0.41–1.26]
P = 0.248
CG vs. CD
OR, 95% CI
P-value
OR = 0.67 CI = [0.32–1.40] P = 0.285 OR = 2.17 CI = [0.45–10.35] P = 0.322 OR = 2.56 CI = [0.51–12.84] P = 0.239 OR = 1.412 CI = [0.81–2.48] OR = 0.71 CI = [0.40–1.24]
P = 0.228
CD vs. UC
OR, 95% CI
P-value
OR = 0.93 CI = [0.53–1.64] P = 0.794 OR = 0.88 C.I. = [0.36–2.17] P = 0.780 OR = 0.932 CI = [0.36–2.44] P = 0.887 OR = 1.01 CI = [0.67–1.53] OR = 0.99 CI = [0.65–1.49]
P = 0.951

No corrections for the multiple statistical testing were made. CG—control group, [GG + GA] vs. [AA]—dominant model, risk allele: G, [GG] vs. [GA + AA]—recessive model, risk allele: A, * Allele frequencies for European population according to 1000Genomes Project have been gathered from https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=ss1322898670 website [42].